ICUI logo

ICU Medical Inc


ICUI: ICU Medical is a California-based, pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017, and Smiths Medical from Smiths Group in 2022. It holds top-tier positions in its original reporting segments: infusion consumables (25% of 2022 revenue), IV solutions (16%), infusion systems (15%), and critical care (2%) as well as its new Smiths segments: Smiths infusion systems (15%), vascular access (14%), and vital care (12%). The combined entity remains primarily U.S. focused, generating over 64% of its sales domestically.


Show ICUI Financials

Consumer Interest
SEC Filings

Recently reported changes by institutional investors

Quarterly net insider trading by ICUI's directors and management

Government lobbying spending instances

  • $10,000 Apr 21, 2014 Issue: Health Issues
  • $20,000 Jan 21, 2014 Issue: Health Issues
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases


Number of mentions of ICUI in WallStreetBets Daily Discussion


Recent insights relating to ICUI

CNBC Recommendations

Recent picks made for ICUI stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ICUI

Corporate Flights

Flights by private jets registered to ICUI